Published in Cancer Manag Res on February 16, 2012
Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis. Front Immunol (2014) 0.96
Emerging significance of NLRs in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.86
Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment. Breast Cancer (Dove Med Press) (2013) 0.81
Integrative systems of genomic risk markers for cancer and other diseases: future of predictive medicine. Cancer Manag Res (2012) 0.81
Cancer: A Tale of Aberrant PRR Response. Front Immunol (2014) 0.76
Editorial: Pattern Recognition Receptors and Cancer. Front Immunol (2015) 0.75
The Goldilocks Conundrum: NLR Inflammasome Modulation of Gastrointestinal Inflammation during Inflammatory Bowel Disease. Crit Rev Immunol (2016) 0.75
Pattern recognition receptors and DNA repair: starting to put a jigsaw puzzle together. Front Immunol (2014) 0.75
No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations. Onco Targets Ther (2017) 0.75
A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science (2004) 14.80
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity (2011) 11.15
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem (2003) 10.79
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem (1999) 7.81
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem (1999) 7.38
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol (2004) 7.22
Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol (1999) 6.60
Immune signaling by RIG-I-like receptors. Immunity (2011) 5.02
Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med (2004) 4.47
Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol (2010) 4.07
CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology (2003) 3.70
Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol (2003) 2.82
Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One (2009) 2.79
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology (2006) 2.78
Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest (2007) 2.55
Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem (2004) 2.18
Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol (2007) 2.14
A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem (2007) 2.05
Regulation of the antimicrobial response by NLR proteins. Immunity (2011) 2.04
NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog (2005) 2.04
Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep (2009) 1.97
Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity (2011) 1.96
Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther (2003) 1.94
Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect Immun (2004) 1.77
Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol (2007) 1.76
Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol (2008) 1.70
Role of Toll-like receptors in gastrointestinal malignancies. Oncogene (2008) 1.69
Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol (2007) 1.65
Functional variant in the 3'-untranslated region of Toll-like receptor 4 is associated with nasopharyngeal carcinoma risk. Cancer Biol Ther (2006) 1.55
Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res (2008) 1.45
Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. Cell Microbiol (2006) 1.44
Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res (2010) 1.40
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. Cell Host Microbe (2008) 1.35
Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck (2009) 1.34
Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J Immunol (2006) 1.32
Toll-like receptors, inflammation and cancer. Semin Cancer Biol (2005) 1.29
Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? Br J Cancer (2006) 1.23
Toll-like receptor signaling in anti-cancer immunity. J Med Invest (2003) 1.22
Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol Immunother (2009) 1.21
Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk. Hum Immunol (2011) 1.18
Dectin-1 and Dectin-2 in innate immunity against fungi. Int Immunol (2011) 1.13
A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni. Cell Microbiol (2007) 1.11
Role of toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Mosc) (2008) 1.09
Lung cancer and Toll-like receptors. Cancer Immunol Immunother (2011) 1.06
Role of bacteria in oncogenesis. Clin Microbiol Rev (2010) 1.05
Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Hum Immunol (2010) 1.04
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs. Hered Cancer Clin Pract (2005) 1.04
Chronic bacterial and parasitic infections and cancer: a review. J Infect Dev Ctries (2010) 1.03
Infections and immune factors in cancer: the role of epidemiology. Oncogene (2004) 1.03
Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs. J Biol Chem (2001) 1.02
Schistosoma mansoni worm glycolipids induce an inflammatory phenotype in human dendritic cells by cooperation of TLR4 and DC-SIGN. Mol Immunol (2010) 1.02
Characterization of nucleotide-binding oligomerization domain (NOD) protein expression in primary murine microglia. J Neuroimmunol (2006) 1.01
Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol (2009) 1.01
Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Anticancer Res (2003) 0.98
Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer. Med Oncol (2011) 0.92
Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer (2010) 0.92
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis. Gastroenterol Res Pract (2010) 0.91
Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Liver Int (2010) 0.90
C/T polymorphism in the 5' untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb Vasc Biol (1995) 0.89
TLRs, Alcohol, HCV, and Tumorigenesis. Gastroenterol Res Pract (2011) 0.88
Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: a nested case-control study. APMIS (2008) 0.88
Single nucleotide polymorphism in 5'-flanking region reduces transcription of surfactant protein B gene in H441 cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.88
Toll-like receptors and their role in hematologic malignancies. Curr Mol Med (2009) 0.86
Collectins and fungal pathogens: roles of surfactant proteins and mannose binding lectin in host resistance. Med Mycol (2010) 0.86
Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Anticancer Res (2009) 0.86
Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Hum Immunol (2011) 0.86
DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4. PLoS One (2011) 0.85
Primers on molecular pathways: lipopolysaccharide signaling - potential role in pancreatitis and pancreatic cancer. Pancreatology (2010) 0.84
The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans. Vaccine (2009) 0.83
The C-type lectin CD209b is expressed on microglia and it mediates the uptake of capsular polysaccharides of Streptococcus pneumoniae. Neurosci Lett (2008) 0.82
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population. Hum Immunol (2009) 0.82
The role of C-type lectins in the innate immunity against pulmonary pathogens. Adv Exp Med Biol (2000) 0.79
CARD15 mutations and colorectal cancer in a South European country. Int J Colorectal Dis (2010) 0.79
Infectious causes of esophageal cancer. Infect Dis Clin North Am (2010) 0.77
C-type lectins in immunity to Mycobacterium tuberculosis. Front Biosci (Schol Ed) (2011) 0.77
Polymorphisms in Toll-like receptor genes--implications for prostate cancer development. Coll Antropol (2010) 0.76
[Establishment of a bladder cancer cell line with toll-like receptor 2 gene knockdown and identification of its biological characteristics]. Nan Fang Yi Ke Da Xue Xue Bao (2010) 0.76
The role of calcifying nanoparticles in biology and medicine. Int J Nanomedicine (2012) 0.91
Colorectal cancer risk factors among the population of South-East Siberia: a case-control study. Asian Pac J Cancer Prev (2012) 0.88
Genetic predisposition to calcific aortic stenosis and mitral annular calcification. Mol Biol Rep (2014) 0.85
C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map. Cancer Manag Res (2012) 0.84
Are Toll-like receptor gene polymorphisms associated with prostate cancer? Cancer Manag Res (2012) 0.80
Correlation between genetic polymorphisms within IL-1B and TLR4 genes and cancer risk in a Russian population: a case-control study. Tumour Biol (2014) 0.80
Analysis of cancer incidence and mortality in the industrial region of South-East Siberia from 1991 through 2010. Asian Pac J Cancer Prev (2012) 0.77